Safety, pharmacokinetics, and pharmacodynamics of Dapagliflozin (BMS-512148) in an ascending, placebo-controlled, multiple-dose study in healthy adult subjects

被引：0
|
作者：
Brenner, E. [1 ]
Komoroski, B. [1 ]
Boulton, D. [1 ]
Li, L. [1 ]
机构：
[1] Bristol Myers Squibb Co, Princeton, NJ 08543 USA
来源：
DIABETOLOGIA | 2007年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0765
引用
收藏
页码：S316 / S316
页数：1
相关论文
共 50 条
  • [41] Safety, tolerability, pharmacokinetics and neutrophil elastase inhibitory effects of Sivelestat: A randomized, double-blind, placebo-controlled singleand multiple-dose escalation study in Chinese healthy subjects
    Li, Kun
    Dong, Lingfang
    Gao, Shan
    Zhang, Jingying
    Feng, Yinghua
    Gu, Li
    Yang, Jie
    Liu, Xing
    Wang, Yaqin
    Mao, Zhenkun
    Jiang, Dandan
    Xia, Zhengchao
    Zhang, Guoliang
    Tang, Jingwen
    Ma, Peizhi
    Zhang, Wei
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 195
  • [42] Safety, Pharmacokinetics, and Pharmacodynamics of Etrasimod: Single and Multiple Ascending Dose Studies in Healthy Adults
    Lee, Caroline A.
    Schreiber, Stefan
    Bressler, Brian
    Adams, John W.
    Oh, Dooman Alexander
    Tang, Yong Q.
    Zhang, Jinkun
    Komori, Heather Kiyomi
    Grundy, John S.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (05): : 534 - 548
  • [43] Evaluation of safety, tolerability, and multiple-dose pharmacokinetics of istradefylline in healthy subjects.
    Rao, N.
    Uchimura, T.
    Mori, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S99 - S99
  • [44] Multiple-dose tolerability, safety, pharmacokinetics, and pharmacodynamics of the urotensin-II receptor antagonist palosuran in healthy human subjects
    Sidharta, PN
    van Giersbergen, PLM
    Schaarschmidt, D
    Dingemanse, J
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 60 (06) : 677 - 678
  • [45] A RANDOMIZED, SINGLE-CENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE, PHASE 1 STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS (PK), AND PHARMACODYNAMICS (PD) OF TAK-272 IN HEALTHY ADULT NON-ELDERLY AND ELDERLY MALE SUBJECTS
    Matsuno, K.
    Tanaka, S.
    Hashimoto, T.
    Nakamichi, H.
    Komura, E.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 265 - +
  • [46] A placebo-controlled, randomized, single and multiple dose study to evaluate the safety, tolerability, and pharmacokinetics of rimegepant in healthy participants
    Bertz, Richard
    Bhardwaj, Rajinder
    Morris, Beth A. A.
    Ashbrenner, Eric
    Coric, Vladimir
    Croop, Robert
    CEPHALALGIA, 2023, 43 (06)
  • [47] A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE AND MULTIPLE ASCENDING DOSE STUDY TO EVALUATE THE SAFETY AND PHARMACOKINETICS OF OCR-002 IN HEALTHY VOLUNTEERS
    Jochelson, P.
    van de Wetering, J. L.
    Bornstein, J.
    Resler, M.
    Anderson, K.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S70 - S70
  • [48] ASCENDING MULTIPLE-DOSE STUDY WITH PONESIMOD, A SELECTIVE SIP1 RECEPTOR AGONIST: TOLERABILITY, SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS
    Brossard, P.
    Maatouk, H.
    Halabi, A.
    Dingemanse, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S93 - S93
  • [49] Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Sotagliflozin After Multiple Ascending Doses in Chinese Healthy Subjects
    He, Xuemei
    Gao, Xin
    Xie, Panpan
    Liu, Yuan
    Bai, Wenjing
    Liu, Yue
    Shi, Aixin
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 2967 - 2980
  • [50] Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of TAK-935 in Healthy Subjects
    Wang, Shining
    Chen, Grace
    Uz, Tolga
    Affinito, John
    NEUROLOGY, 2018, 90
12345